Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTs.
Stem Cell Res Ther
; 13(1): 275, 2022 06 25.
Article
in En
| MEDLINE
| ID: mdl-35752865
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Respiratory Distress Syndrome
/
Mesenchymal Stem Cells
Type of study:
Clinical_trials
/
Prognostic_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Stem Cell Res Ther
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Reino Unido